From Financial institution of Baroda’s deliberate NSE OFS and Biocon’s block deal to contemporary orders for Innovision, Enviro Infra and TCS, listed below are the shares to trace forward…
1/11Financial institution of Baroda | The financial institution plans to divest as much as 76,90,375 NSE shares, equal to 35% of its holding, via an Supply for Sale as a part of NSE’s proposed IPO, topic to regulatory approvals. The shares have been transferred to an escrow account on September 8, with the sale anticipated to be accomplished by the tip of September.
2/11Biocon | Energetic Pine is more likely to promote as much as 1.66 crore shares, or a 1% stake, in Biocon via a block deal price round ₹638.4 crore. The ground value has been set at ₹385 per share, implying a reduction of as much as 1.9% to the present market value. The vendor can be topic to a 30-day lock-up interval for any additional stake sale.
3/11Innovision | The agency has secured two work orders price a mixed ₹243.60 crore from NHAI for toll assortment and facility upkeep at freeway payment plazas in Madhya Pradesh. The bigger ₹219.07 crore contract covers toll assortment and upkeep on the IDTL A and B payment plazas on the six-laning undertaking of the Indore-Dewas part of NH-3, together with repairs of adjoining rest room blocks.
4/11Enviro Infra Engineers | The agency mentioned its step-down subsidiary Suyog Urja has secured a ₹189.99 crore contract, excluding GST, from Tata Energy Renewable Vitality for EPC turnkey works for a 180 MW NTPC wind energy undertaking at Parli, Maharashtra. The order, awarded on September 7, covers wind turbine basis, Stability of Plant and 33-kV transmission line works, and is scheduled for completion by March 31, 2027.
5/11Nice Japanese Delivery Firm | The delivery main has contracted to accumulate a secondhand 81,609-dwt Kamsarmax dry bulk service in-built 2019, with supply anticipated in Q3 FY27. The corporate mentioned the acquisition will develop its fleet and be funded solely via inner accruals.
6/11Sanofi India | The agency mentioned the Supreme Courtroom has dismissed its petition difficult felony proceedings linked to a CBI grievance over pharmaceutical provides to BARC, Mysore, between 2012 and 2015. The corporate mentioned the September 7 order doesn’t report any discovering of guilt or determine the deserves of the case, however issues whether or not prosecution can proceed with none particular person worker being arraigned.
7/11Raymond | The agency will increase as much as ₹214.71 crore via a preferential subject of 33,28,686 convertible warrants to Minerva Ventures Fund, in line with a regulatory submitting on Tuesday. The warrants can be issued at ₹645 every, with every warrant carrying the appropriate to subscribe to 1 fairness share on the similar value. The fundraise, permitted by the board on September 8, is topic to shareholder and regulatory approvals.
8/11MosChip | The agency mentioned the Supreme Courtroom has directed respondents in a dispute linked to its proposed acquisition of 73% of Vayavya Labs to furnish a further ₹200 crore safety by September 15. The corporate mentioned it has no reference to the underlying dispute and that the order entails no violation or discovering of guilt towards it.
9/11Bajaj Finance | The corporate has allotted 2,05,000 secured NCDs of ₹1 lakh face worth every, aggregating ₹2,050.03 crore, on a non-public placement foundation. The NCDs carry an 8.07% annual coupon, have a tenure of 1,294 days and mature on March 25, 2030. They are going to be listed on the BSE Wholesale Debt Market phase.
10/11Tata Consultancy Companies | TCS has secured a ₹122.6 crore contract from the Odisha authorities to implement OSWAS 3.0, extending its partnership by round six years. The undertaking will combine workflow automation, analytics, safety and AI capabilities on a standard digital platform. The present OSWAS platform is used throughout greater than 4,600 authorities places of work and by almost 50,000 customers in Odisha.tion.
11/11Laxmi Natural Industries | The agency mentioned Rajan Venkatesh will resign as MD & CEO efficient November 13, 2026. Harshvardhan Goenka will take over as MD & CEO from November 14 for a five-year time period.
